Literature DB >> 15981091

Axon reactive B cells clonally expanded in the cerebrospinal fluid of patients with multiple sclerosis.

Yiping Zhang1, Reng-Rong Da, Wenzhong Guo, Hui-Min Ren, Lutz G Hilgenberg, Raymond A Sobel, Wallace W Tourtellotte, Martin A Smith, Michael Olek, Sudhir Gupta, Richard T Robertson, Rashed Nagra, Stanley Van Den Noort, Yufen Qin.   

Abstract

Demyelination and axonal loss have been described as the histological hallmarks of inflammatory lesions of multiple sclerosis (MS) and are the pathological correlates of persistent disability. However, the immune mechanisms underlying axonal damage in MS remain unknown. Here, we report the use of single chain-variable domain fragments (scFv) from clonally expanded cerebrospinal fluid (CSF) B cells to show the role of an anti-axon immune response in the central nervous system (CNS) in MS. The cellular and subcellular distribution of the antigen(s) recognized by these CSF-derived clonal scFv antibodies (CSFC-scFv Abs) was studied by immunochemical staining of brain tissues obtained at autopsy from patients with MS. Immunochemistry showed specific binding of CSFC-scFv Abs to axons in acute MS lesions. The stained axons showed three major types of axonal pathological changes: 1) linear axons, axonal ovoid formation, and axonal transection were seen in the myelinated white matter adjacent to the lesion; 2) accumulation of axonal ovoid formations and Wallerian degeneration were seen at the border between demyelinated lesions and the adjacent white matter; and 3) Wallerian degeneration occurred at the center and edge of acute demyelinated lesions. These findings suggest a B cell axonal specific immune response in the CNS in MS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15981091     DOI: 10.1007/s10875-005-4083-5

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  40 in total

1.  Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid.

Authors:  Gregory P Owens; Alanna M Ritchie; Mark P Burgoon; R Anthony Williamson; John R Corboy; Donald H Gilden
Journal:  J Immunol       Date:  2003-09-01       Impact factor: 5.422

2.  Length of the antibody heavy chain complementarity determining region 3 as a specificity-determining factor.

Authors:  Yvelise Barrios; Pernilla Jirholt; Mats Ohlin
Journal:  J Mol Recognit       Date:  2004 Jul-Aug       Impact factor: 2.137

Review 3.  Antigen-driven selection of virgin and memory B cells.

Authors:  I C MacLennan; D Gray
Journal:  Immunol Rev       Date:  1986-06       Impact factor: 12.988

4.  Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.

Authors:  C Lucchinetti; W Brück; J Parisi; B Scheithauer; M Rodriguez; H Lassmann
Journal:  Ann Neurol       Date:  2000-06       Impact factor: 10.422

5.  Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values.

Authors:  G Tibbling; H Link; S Ohman
Journal:  Scand J Clin Lab Invest       Date:  1977-09       Impact factor: 1.713

Review 6.  On cerebrospinal fluid immunoglobulin-G (IgG) quotients in multiple sclerosis and other diseases. A review and a new formula to estimate the amount of IgG synthesized per day by the central nervous system.

Authors:  W Tourtellotte
Journal:  J Neurol Sci       Date:  1970-03       Impact factor: 3.181

7.  Vaccination against autoimmune encephalomyelitis with T-lymphocyte line cells reactive against myelin basic protein.

Authors:  A Ben-Nun; H Wekerle; I R Cohen
Journal:  Nature       Date:  1981-07-02       Impact factor: 49.962

8.  B cell repertoire diversity and clonal expansion in multiple sclerosis brain lesions.

Authors:  S E Baranzini; M C Jeong; C Butunoi; R S Murray; C C Bernard; J R Oksenberg
Journal:  J Immunol       Date:  1999-11-01       Impact factor: 5.422

9.  Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis.

Authors:  Y Qin; P Duquette; Y Zhang; P Talbot; R Poole; J Antel
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

Review 10.  Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis.

Authors:  P M Matthews; N De Stefano; S Narayanan; G S Francis; J S Wolinsky; J P Antel; D L Arnold
Journal:  Semin Neurol       Date:  1998       Impact factor: 3.420

View more
  14 in total

Review 1.  Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis.

Authors:  Lisa K Peterson; Robert S Fujinami
Journal:  J Neuroimmunol       Date:  2006-12-28       Impact factor: 3.478

2.  Peptide reactivity between multiple sclerosis (MS) CSF IgG and recombinant antibodies generated from clonally expanded plasma cells in MS CSF.

Authors:  Xiaoli Yu; Don Gilden; Laura Schambers; Olga Barmina; Mark Burgoon; Jeffrey Bennett; Greg Owens
Journal:  J Neuroimmunol       Date:  2010-12-21       Impact factor: 3.478

Review 3.  A case for regulatory B cells in controlling the severity of autoimmune-mediated inflammation in experimental autoimmune encephalomyelitis and multiple sclerosis.

Authors:  Avijit Ray; Monica K Mann; Sreemanti Basu; Bonnie N Dittel
Journal:  J Neuroimmunol       Date:  2010-12-10       Impact factor: 3.478

4.  B cells contribute to MS pathogenesis through antibody-dependent and antibody-independent mechanisms.

Authors:  Heather L Wilson
Journal:  Biologics       Date:  2012-05-07

Review 5.  Does disease-irrelevant intrathecal synthesis in multiple sclerosis make sense in the light of tertiary lymphoid organs?

Authors:  Mickael Bonnan
Journal:  Front Neurol       Date:  2014-03-11       Impact factor: 4.003

6.  Characterization of immune response to neurofilament light in experimental autoimmune encephalomyelitis.

Authors:  Fabiola Puentes; Baukje J van der Star; Marion Victor; Markus Kipp; Cordian Beyer; Regina Peferoen-Baert; Kimberley Ummenthum; Gareth Pryce; Wouter Gerritsen; Ruth Huizinga; Arie Reijerkerk; Paul van der Valk; David Baker; Sandra Amor
Journal:  J Neuroinflammation       Date:  2013-09-22       Impact factor: 8.322

7.  Chaperoned amyloid proteins for immune manipulation: α-Synuclein/Hsp70 shifts immunity toward a modulatory phenotype.

Authors:  Adahir Labrador-Garrido; Marta Cejudo-Guillén; Rebecca Klippstein; Erwin J De Genst; Laura Tomas-Gallardo; María M Leal; Javier Villadiego; Juan J Toledo-Aral; Christopher M Dobson; David Pozo; Cintia Roodveldt
Journal:  Immun Inflamm Dis       Date:  2014-12-05

Review 8.  Perturbed glucose metabolism: insights into multiple sclerosis pathogenesis.

Authors:  Deepali Mathur; Gerardo López-Rodas; Bonaventura Casanova; Maria Burgal Marti
Journal:  Front Neurol       Date:  2014-12-01       Impact factor: 4.003

Review 9.  Heterogeneity of B Cell Functions in Stroke-Related Risk, Prevention, Injury, and Repair.

Authors:  Uma Maheswari Selvaraj; Katherine Poinsatte; Vanessa Torres; Sterling B Ortega; Ann M Stowe
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

10.  B cells and monocytes from patients with active multiple sclerosis exhibit increased surface expression of both HERV-H Env and HERV-W Env, accompanied by increased seroreactivity.

Authors:  Tomasz Brudek; Tove Christensen; Lars Aagaard; Thor Petersen; Hans J Hansen; Anné Møller-Larsen
Journal:  Retrovirology       Date:  2009-11-16       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.